IBDEI1FM ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23161,1,3,0)
 ;;=3^Acrodermatitis continua
 ;;^UTILITY(U,$J,358.3,23161,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,23161,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,23162,0)
 ;;=L40.3^^78^1003^29
 ;;^UTILITY(U,$J,358.3,23162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23162,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,23162,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,23162,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,23163,0)
 ;;=L40.4^^78^1003^25
 ;;^UTILITY(U,$J,358.3,23163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23163,1,3,0)
 ;;=3^Psoriasis,Guttate
 ;;^UTILITY(U,$J,358.3,23163,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,23163,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,23164,0)
 ;;=L40.8^^78^1003^26
 ;;^UTILITY(U,$J,358.3,23164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23164,1,3,0)
 ;;=3^Psoriasis,Other
 ;;^UTILITY(U,$J,358.3,23164,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,23164,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,23165,0)
 ;;=L72.3^^78^1003^31
 ;;^UTILITY(U,$J,358.3,23165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23165,1,3,0)
 ;;=3^Sebaceous cyst
 ;;^UTILITY(U,$J,358.3,23165,1,4,0)
 ;;=4^L72.3
 ;;^UTILITY(U,$J,358.3,23165,2)
 ;;=^5009281
 ;;^UTILITY(U,$J,358.3,23166,0)
 ;;=L97.919^^78^1003^21
 ;;^UTILITY(U,$J,358.3,23166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23166,1,3,0)
 ;;=3^Non-pressure chr ulcer unspec part right lower leg
 ;;^UTILITY(U,$J,358.3,23166,1,4,0)
 ;;=4^L97.919
 ;;^UTILITY(U,$J,358.3,23166,2)
 ;;=^5133688
 ;;^UTILITY(U,$J,358.3,23167,0)
 ;;=L97.929^^78^1003^20
 ;;^UTILITY(U,$J,358.3,23167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23167,1,3,0)
 ;;=3^Non-pressure chr ulcer unspec part left lower leg
 ;;^UTILITY(U,$J,358.3,23167,1,4,0)
 ;;=4^L97.929
 ;;^UTILITY(U,$J,358.3,23167,2)
 ;;=^5133689
 ;;^UTILITY(U,$J,358.3,23168,0)
 ;;=L98.499^^78^1003^19
 ;;^UTILITY(U,$J,358.3,23168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23168,1,3,0)
 ;;=3^Non-pressure chr skin ulcer
 ;;^UTILITY(U,$J,358.3,23168,1,4,0)
 ;;=4^L98.499
 ;;^UTILITY(U,$J,358.3,23168,2)
 ;;=^5009591
 ;;^UTILITY(U,$J,358.3,23169,0)
 ;;=L98.9^^78^1003^33
 ;;^UTILITY(U,$J,358.3,23169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23169,1,3,0)
 ;;=3^Skin/Subcutaneous tissue disorder, unspec
 ;;^UTILITY(U,$J,358.3,23169,1,4,0)
 ;;=4^L98.9
 ;;^UTILITY(U,$J,358.3,23169,2)
 ;;=^5009595
 ;;^UTILITY(U,$J,358.3,23170,0)
 ;;=L20.81^^78^1003^15
 ;;^UTILITY(U,$J,358.3,23170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23170,1,3,0)
 ;;=3^Dermatitis,Atopic
 ;;^UTILITY(U,$J,358.3,23170,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,23170,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,23171,0)
 ;;=L23.81^^78^1003^7
 ;;^UTILITY(U,$J,358.3,23171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23171,1,3,0)
 ;;=3^Dermatitis,Allergic Contact,Animal Dander
 ;;^UTILITY(U,$J,358.3,23171,1,4,0)
 ;;=4^L23.81
 ;;^UTILITY(U,$J,358.3,23171,2)
 ;;=^5009123
 ;;^UTILITY(U,$J,358.3,23172,0)
 ;;=L23.2^^78^1003^8
 ;;^UTILITY(U,$J,358.3,23172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23172,1,3,0)
 ;;=3^Dermatitis,Allergic Contact,Cosmetics
 ;;^UTILITY(U,$J,358.3,23172,1,4,0)
 ;;=4^L23.2
 ;;^UTILITY(U,$J,358.3,23172,2)
 ;;=^5009117
 ;;^UTILITY(U,$J,358.3,23173,0)
 ;;=L23.3^^78^1003^9
 ;;^UTILITY(U,$J,358.3,23173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23173,1,3,0)
 ;;=3^Dermatitis,Allergic Contact,Drugs on Skin
 ;;^UTILITY(U,$J,358.3,23173,1,4,0)
 ;;=4^L23.3
